IVVD

Invivyd Announces Closing of $57.5 Million Public Offering and Full Exercise of the Underwriter’s Option to Purchase Additional Shares

08/22 12:00 pm

Invivyd Announces Pricing of $50 Million Public Offering of Common Stock and Pre-Funded Warrants

08/20 11:58 pm

Invivyd Announces Continued Neutralizing Activity of PEMGARDA® (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (“Stratus”)

08/18 04:32 pm

Invivyd Revenue Jumps 413 Percent in Q2

08/14 07:05 pm

Invivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business Highlights

03/20 08:01 am

Invivyd to Participate in the Guggenheim Securities Healthcare Innovation Conference

11/06 09:01 am

Invivyd to Host Third Quarter 2024 Financial Results and Corporate Update Conference Call on November 14, 2024

11/06 08:01 am

Invivyd to Present PEMGARDA™ (pemivibart) Data at Infectious Disease Week (IDWeek) 2024

10/16 07:01 am

Invivyd Announces its Addition to the Russell 2000® and Russell 3000® Indexes

07/01 07:01 am

Invivyd Announces Antiviral Activity of VYD222 (pemivibart) Against SARS-CoV-2 KP.1.1 FLiRT & KP.3 Variants

06/14 07:01 am

Invivyd to Participate at the Jefferies Global Healthcare Conference

06/03 04:01 pm

Invivyd Announces General Alignment with U.S. FDA on a Repeatable, Expedient Emergency Use Authorization Pathway for the Prevention and Treatment of Symptomatic COVID-19, Based on Compact Clinical Programs to Establish Safety and Immunobridging for Serial Monoclonal Antibodies

05/31 07:05 am

Invivyd Announces the Appointment of Timothy Lee as Chief Commercial Officer

05/31 07:00 am

Invivyd Elects Two New Independent Members to its Board of Directors

05/22 07:00 am

Invivyd to Participate at the H.C. Wainwright 2nd Annual BioConnect Investor Conference

05/13 04:01 pm

Invivyd Reports First Quarter 2024 Financial Results and Recent Business Highlights

05/09 04:01 pm

Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA Feedback

05/07 07:30 am

Invivyd to Host Conference Call Discussing First Quarter 2024 Financial Results and Business Highlights

05/02 05:13 pm

Invivyd Announces $20 Million to $25 Million Improvement in Projected 2024 Year-End Cash Position

04/30 07:30 am

Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™

04/15 07:30 am

Invivyd Announces CEO Transition

04/12 07:30 am

Kura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session

04/05 08:01 am

Invivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 Million

04/04 04:01 pm

Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights

03/28 07:00 am

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

03/26 01:45 pm

Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday

03/26 10:36 am

Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket

03/26 08:00 am

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session

03/25 02:44 pm

Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday

03/25 10:32 am

Why Salarius Pharmaceuticals Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket

03/25 08:03 am

Invivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Clinical Trial

03/22 03:28 pm

Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19

03/22 03:04 pm

Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session

02/12 02:07 pm

Invivyd to Participate at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

02/05 05:02 pm

Apple To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Thursday

01/18 08:50 am

All You Need to Know About Invivyd, Inc. (IVVD) Rating Upgrade to Strong Buy

01/12 01:00 pm

Invivyd Stock More Than Doubled Last Week. Is It Too Late to Buy?

12/23 06:29 am

Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

12/19 02:34 pm

Invivyd (IVVD) Surges on Positive Data From COVID-19 Study

12/19 12:52 pm

Bluebird Bio, Vertex Energy And Other Big Stocks Moving Lower On Tuesday

12/19 11:19 am

Nasdaq Gains 100 Points; Biomerica Shares Spike Higher

12/18 03:21 pm

Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session

12/18 02:05 pm

Crude Oil Rises 3%; US Housing Market Index Increases In December

12/18 01:17 pm

Invivyd Announces Positive Initial Results from Ongoing CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of COVID-19

12/18 08:00 am

Invivyd to Host Conference Call Discussing Third Quarter 2023 Financial Results and Business Highlights

11/02 04:01 pm

Invivyd to Participate in Upcoming Investor Conferences

10/31 04:01 pm

Invivyd Announces Dosing of First Participant in CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of Symptomatic COVID-19 

09/11 07:00 am

Invivyd (IVVD) Stock Rises 18% in 3 Months: Here's Why

08/29 01:13 pm

Invivyd Reports Second Quarter 2023 Financial Results and Business Highlights

08/10 04:01 pm

Invivyd to Host Conference Call Discussing Second Quarter 2023 Financial Results and Business Highlights

08/03 04:01 pm